Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Case Report: Semaglutide-associated depression: a report of two cases
Jiarui Li, Jinya Cao, Jing Wei, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
Jianxing Zhou, You Zheng, Baohua Xu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Wenchao Lu, Shihan Wang, Huilin Tang, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access | Times Cited: 1
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy
Edy Kornelius, Jing‐Yang Huang, Shih‐Chang Lo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
Silvia Tempia Valenta, Alba Nicastri, Federica Perazza, et al.
Current Treatment Options in Psychiatry (2024)
Closed Access | Times Cited: 5
Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists
Liya Kerem, Joshua Stokar
JAMA Pediatrics (2024)
Closed Access | Times Cited: 4
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access
Mental Health After Childbirth in Women with Previous Bariatric Surgery: The SPOtMom Pilot Study
Ulrike Plank, K Wehrmann, Filiz Oehlhof, et al.
Experimental and Clinical Endocrinology & Diabetes (2025) Vol. 133, Iss. 03, pp. 112-119
Open Access
Mental Health Factors in Semaglutide Discontinuation
Michioki Endo, Masahiro Kami
JAMA Internal Medicine (2025)
Closed Access
Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study
Xiang Lin, Ying Peng
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2741-2741
Open Access
What Is Food Noise? A Conceptual Model of Food Cue Reactivity
Daisuke Hayashi Neto, Caitlyn G. Edwards, Jennifer A. Emond, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4809-4809
Open Access | Times Cited: 12
Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3–36 in the suppression of food, drug-seeking, and anxiogenesis
Yasmina Dumiaty, Brett M. Underwood, Jenny Phy-Lim, et al.
Neuropeptides (2024) Vol. 105, pp. 102427-102427
Open Access | Times Cited: 4
Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations
Sujatha Seetharaman, Eda Cengiz
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 2
Association between Symptoms of Depression and Generalised Anxiety Disorder Evaluated through PHQ-9 and GAD-7 and Anti-Obesity Treatment in Polish Adult Women
Tomasz Witaszek, Karolina Kłoda, Agnieszka Mastalerz‐Migas, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2438-2438
Open Access | Times Cited: 1
TRPV1: a novel target for the therapy of diabetes and diabetic complications
Yu-Rong Shen, Long Cheng, Dongfang Zhang
European Journal of Pharmacology (2024), pp. 177021-177021
Closed Access | Times Cited: 1
Association Between Symptoms of Depression and Generalised Anxiety Disorder evaluated through PHQ-9 and GAD-7 and anti-obesity treatment in Polish Adult Women
Tomasz Witaszek, Karolina Kłoda, Agnieszka Mastalerz‐Migas, et al.
Research Square (Research Square) (2024)
Closed Access
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J. Modestino, Abdalla Bowirrat, Kai‐Uwe Lewandrowski, et al.
Acta Scientific Neurology (2024), pp. 12-18
Open Access
Is physical activity still the key to treating obesity? - semaglutide, a new position among therapies
Karolina Makowska, Marta Billewicz, Aleksandra Marczyk, et al.
Quality in Sport (2024) Vol. 20, pp. 54194-54194
Open Access
Side effects of medications used in the management of diabetes
Manoranjan S. D’Souza, Hannah Salamie, Michael Krmic, et al.
Side effects of drugs annual (2024), pp. 451-466
Closed Access
Linking the reversal of gestational insulin resistance to postpartum depression
Minoli Vinoda Abeysekera, Duan Ni, Leah Gilbert, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
The safety of semaglutide in patients with depression and obesity
Ziyi Yang, Yimin Yan
Obesity (2024) Vol. 32, Iss. 12, pp. 2217-2217
Closed Access
The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-like Peptide Receptor Agonists
Sujatha Seetharaman, Eda Cengiz
Journal of Diabetes Science and Technology (2024)
Closed Access
Online Information about Side-effects and Safety Concerns of Semaglutide: Analysis of YouTube videos (Preprint)
Andy Wai Kan Yeung, Fabian Peter Hammerle, S Behrens, et al.
JMIR Infodemiology (2024)
Open Access
Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos (Preprint)
Andy Wai Kan Yeung, Fabian Peter Hammerle, S Behrens, et al.
(2024)
Closed Access
Mental Health Implications of Weight Loss Medications: A Narrative Review
Shari Harding
The Journal for Nurse Practitioners (2024) Vol. 20, Iss. 10, pp. 105207-105207
Closed Access
Central nervous system stimulants and drugs that suppress appetite
Elif Ece Akgün, Mehmet Uzumcu, Nicholas T. Bello
Side effects of drugs annual (2024), pp. 547-561
Closed Access
Page 1 - Next Page

Scroll to top